Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.

We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.

Although the primary focus is on conditions on the autism spectrum (including Asperger syndrome), the scope encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.

Molecular Autism also considers articles with no molecular data but which, in the long-term, may close the gap from molecule to behavior in autism. The journal welcomes reports and reviews of good science that proceed from either end of this complex chain of events: from molecule upwards, or from behavior downwards. Reports and reviews can be basic and/or translational. Note that, because we rarely accept unsolicited reviews, we strongly encourage authors of potential reviews to make use of the presubmission inquiry system if they feel that an important topic has not been adequately reviewed and where, ideally, they are proposing a systematic review.

Research
Review
Methodology
Short report
Commentary
Letter to the Editor
Viewpoint

Editors-in-Chief
Simon Baron-Cohen, PhD, University of Cambridge, UK 
Joseph Buxbaum, PhD, Icahn School of Medicine at Mount Sinai, New York, USA
Associate Editors
Evdokia Anagnostou, MD, Holland Bloorview Kids Rehabilitation Hospital, Canada 
Chris Ashwin, PhD, University of Bath, UK
Catalina Betancur, MD, PhD, INSERM, CNRS, Université Pierre et Marie Curie, France 
Richard Bethlehem,  University of Cambridge, UK
Kristen Brennand, PhD, Icahn School of Medicine at Mount Sinai, New York, USA 
Jacqueline N Crawley, PhD, UC Davis MIND Institute, USA
Dorothea Floris,  Radboud University, Netherlands
Rosa Hoekstra, PhD, King's College London, UK
Patrick Hof, MD, Icahn School of Medicine at Mount Sinai, New York, USA 
Meng-Chuan Lai, MD, PhD, University of Toronto, Canada
Michael V Lombardo, PhD, University of Cambridge, UK 
Eva Loth, King's College London, UK
Nadia Micali, MD, MRCPsych, PhD, FAED, Icahn School of Medicine at Mount Sinai, New York, USA
Kazuhiko Nakamura, MD, PhD, Hirosaki University Graduate School of Medicine, Japan 
Cynthia M Schumann, PhD, UC Davis MIND Institute, USA
Jill L. Silverman, University of California Davis, USA
Latha Soorya, PhD, Rush University Medical Center, USA
Varun Warrier, University of Cambridge, UK
Editorial Board
David G Amaral, PhD, University of California, Davis, USA 
Sabine Bahn, MD, PhD, MRCPsych University of Cambridge, UK 
Vanessa Bal, PhD, Rutgers University, USA
Agatino Battaglia, MD, DPed, DNeurol, Stella Maris Clinical Research Institute for Child and Adolescent Neuropsychiatry, Calambrone (Pisa), Italy 
Mark Bear, PhD, Howard Hughes Medical Institute, Massachusetts Institute of Technology, USA
Matthew Belmonte, PhD, National Brain Research Centre, India 
Rita Cantor, PhD, University of California, Los Angeles, USA 
Bhismadev Chakrabarti, PhD, University of Reading, UK
John N Constantino, MD, Washington University School of Medicine, USA 
Emanuel DiCicco-Bloom, MD, Rutgers Robert Wood Johnson Medical School, USA 
Frank Dudbridge, PhD, London School of Hygiene and Tropical Medicine, UK 
Evan E Eichler, PhD, University of Washington School of Medicine, USA 
Jean-Pierre Fryns, MD, Catholic University of Leuven, Belgium 
Jozef Gecz, PhD, University of Adelaide, Australia 
Daniel H Geschwind, MD, PhD, UCLA School of Medicine, USA 
James F Gusella, PhD, Harvard Medical School, USA 
Randi Hagerman, MD, FAAP, University of California, Davis, USA 
Markus Heinrichs, PhD, University of Freiburg, Germany 
Ami Klin, PhD, Marcus Autism Center, Children's Healthcare of Atlanta and Emory University School of Medicine, USA 
Rebecca Knickmeyer, PhD, University of North Carolina at Chapel Hill, USA
Janine LaSalle, PhD, University of California, Davis, USA 
David Ledbetter, PhD, Emory University, USA 
Bennett Leventhal, MD, Nathan Kline Institute for Psychiatric Research, USA 
Rick Livesey, PhD, University of Cambridge, UK 
Catherine E Lord, PhD, Weill Cornell Medical College, USA 
James McCracken, MD, UCLA Neuropsychiatric Institute, USA 
Judith H Miles, MD, PhD, University of Missouri School of Medicine, USA 
Anthony Monaco, MD, PhD, Tufts University, USA 
Eric M Morrow PhD, MD, Brown University, USA
Richard Nowakowski, PhD, Florida State University, USA 
Margaret Pericak-Vance, PhD, University of Miami Miller School of Medicine, USA 
Antonio Persico, MD, University Campus Bio-Medico, Italy 
Louis F Reichardt, PhD, University of California, San Francisco, USA 
Susan Santangelo, ScD, Maine Medical Center Research Institute, USA 
Charles Schwartz, PhD, JC Self Research Institute of Human Genetics, USA 
David Skuse, MD, PhD, University College London, UK 
Matthew State, MD, PhD, Yale University, USA 
Peter Szatmari, MD, University of Toronto, Canada 
Stephen Warren, PhD, Emory University, USA 
Larry J Young, PhD, Emory University, USA